• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2000673 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2020-12-28 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2021-03-15 view
JYSZ2100516 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products License Renew 2021-05-12 view
CYSB2101284 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2021-12-10 Novo Nordisk (China) Pharmaceuticals Co Ltd view
CYSB2000383 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2020-12-23 诺和诺德(中国)制药有限公司 Novo Nordisk (China) Pharmaceuticals Co Ltd Certificate Issued 2021-03-16 view
CYSB2101062 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2021-05-19 Zhuhai United Laboratories Co Ltd view
CYSB2101174 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2021-09-02 Zhuhai United Laboratories Co Ltd view
JYSB2101175 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2021-11-29 Lilly France view
JYSZ2200061 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products License Renew 2022-11-08 view
CYSB2200233 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2022-09-23 Gan & Lee Pharmaceuticals view
JYSZ2200062 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products License Renew 2022-11-08 view
CYSB2300234 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2023-12-21 Gan & Lee Pharmaceuticals view
JYSB2000672 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2020-12-28 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2021-03-15 view
CYSB2101244 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2021-10-28 Lilly Suzhou Pharmaceutical Co Ltd view
JYSB2000671 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2020-12-28 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2021-03-15 view
JYSZ2100507 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products License Renew 2021-04-21 view
CYSB2300203 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2023-11-03 Novo Nordisk (China) Pharmaceuticals Co Ltd view
JYSB2000669 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2020-12-28 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2021-03-15 view
JYSZ2100508 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products License Renew 2021-04-21 view
JYSB2101173 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2021-11-29 Lilly France view
JYSB2000670 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2020-12-28 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2021-03-15 view